The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells

International Journal of Oncology

Volumn 10, Issue 1, 1997, Pages 53-57

  Yamamoto, Manabu ^a   Maehara, Yoshihiko ^b   Sakaguchi, Yoshihisa ^b   Kusumoto, Tetsuya ^a   Baba, Hideo ^c   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Department of Surgery   (Japan)

Author keywords

Apoptosis; Combined effect; Doxorubicin; Vesnarinone

Indexed keywords

DOXORUBICIN; PIPERANOMETOZINE;

ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

EID: 0031037672     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.1.53     Document Type: Article

References (28)

1. Hori M, Inoue M, Tamai J, Koretsune Y, Iwai K, Iwakura K, Kitabatake A, Kamada T: Beneficial effect of OPC-8212 (3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone) on myocardial oxygen consumption in drugs with ischemic heart failure. Jpn Circ J 50: 659-666, 1986.
2. Iijima T, Taira N: Membrane current changes responsible for the positive inotropic effect of OPC-8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heat. J Pharmacol Exp Ther 240: 657-662, 1987.
3. Lathrop DA, Schwartz A: Evidence for possible increase of sodium channel open time and involvement of Na/Ca exchange by a new positive inotropic drug. Eur J Pharmacol 117: 391-392, 1985.
4. Taira N, Endoh M, Iijima N, Satoh K, Yanagisawa T, Yamashita S, Maruyama M, Kawada M, Monta T: Mode and mechanism of action 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart. Arzneim-Forsch 34: 347-355, 1984.
5. Shioi T, Matsumori A, Matsui S, Sasayama S: Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line. Life Sci 54: 11-16, 1993.
6. Sato M, Harada K, Bando T, Shirakami T, Nakashiro K, Yoshida H, Nakai S, Kawai K, Adachi M: Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (Vesnarinone) against a human adenoid squamous carcinoma-forming cell line growth in athymic nude mice. Cancer Lett 91: 1-9, 1995.
7. Murphree SA, Tritton TR, Smith PL, Sartorelli AC: Adriamycin-induced changes in the surface membrane of sarcoma 180 ascites cells. Biochem Biophys Acta 649: 317-324, 1981.
8. Tokes AZ, Roger KE, Rembaum A: Synthesis of adriamycincoupled polyglutaraldehyde microspheres and evaluation of their cytostastic activity. Proc Natl Acad Sci USA 79: 2026-2030, 1982.
9. Triton TR, Yee G: The anticancer agent adriamycin can be actively cytotoxic without entering cells. Science 217: 248-250, 1982.
10. Kizaki H, Ohnishi Y, Mizuno Y, Azuma Y, Mizuno Y, Ohsaka F: Arabinocytosine and 5' azacytisine induce internucleosomal DNA fragmentation and cell death in thymocytes. Immunopharmacology 24: 219-227, 1992.
11. Ling Y-H, Priebe W, Peterz-Soler R: Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug resistance cells. Cancer Res 53: 1845-1852, 1992.
12. Askew DS, Ashmun RA, Simmons BC, Cleveland JL: Constitutive c-myc expression in a IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922, 1991.
13. Colombel M, Olsson CA, Ng P-Y, Buttyan R: Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res 52: 4313-4319, 1992.
14. Arends MK, Wyllie AH: Apoptosis: mechanism and role in pathology. Int Rev Exp Pathol 32: 223-254, 1991.
15. Cohen JJ, Duke RC: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10: 267-293, 1992.
16. Cohen JJ: Overview: mechanism of apoptosis. Immunol Today 14: 126-130, 1993.
17. Peitch MC, Plazar B, Stephan H, Crompton T, McDonald HR, Mannaherz HG, Tschop J: Characterization of the endogenous deoxyribonuclease involved in apoptosis. EMBO J 12: 371-383, 1993.
18. Lowe SW, Ruley HE, Jackes T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
19. Michetich K, Zwelling LA, Kohn KW: Quenching of DNA: platium(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatium(II) in L1210 cells. Cancer Res 43: 3609-3613, 1983.
20. Sakaguchi Y, Maehara Y, Inutsuka S, Takahashi I, Yoshida M, Sugimachi K: Laser flow cytometric studies on the intracellular accumulation of anthracyclines when combined with heat. Cancer Chemother Pharmacol 33: 371-377, 1994.
21. Kamakura T, Takase K, Terada N, Gelfand EW: Vesnarinone inhibited nucleoside and nucleobase transport. Life Sci 57: 75-81, 1995.
22. Johnston JB, Glazer RI (1983) Cellular pharmacology of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) dervatives of 3' deaminodaunorubicin in human colon carcinoma cells in vitro. Cancer Res 83: 1606-1610, 1995.
23. Kusumoto H, Maehara Y, Anai H, Kusumoto T, Sugimachi K: Potentiation of adriamycin cytotoxicity by dipyridamole against HeLa cells in vitro and sarcoma 180 in vivo. Cancer Res 48: 1208-1212, 1988.
24. Yamamoto M, Baba H, Kusumoto T, Sakaguchi Y, Maehara Y, Kuwano M, Sugimachi K: Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle. Anti-Cancer Drugs 6: 570-577, 1995.
25. Takeshita A, Shinjo K, Ohnishi K, Ohno R: New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells biotinylated MRK16 and streptavidin-RED670 conjugate. Jpn J Cancer Res 86: 607-615, 1995.
26. Asoh K, Saburi Y, Sato S, Nogae I, Kohno K, Kuwao K: Potentiation of some anticancer agents by dipyridamole agents drug-sensitive and drug-resistant cancer cell lines. Jpn J Cancer Res 80: 475-481, 1989.
27. Vanderbilt JN, Bloom KS, Anderson JN: Endogenous nuclease. J Bio Chem 257: 13009-13017, 1982.
28. Chafouleas JG, Bolton WE, Means AR: Potentiation of bleomycin lethality by anticalmodulin drugs: A role for calmodulin in DNA repair. Science 224: 1346-1348, 1984.